RESUMOObjetivo: Avaliar o efeito de 12 semanas de exercícios físicos em variáveis associadas a fatores de risco cardiovascular e na atividade da butirilcolinesterase (BChE) em adolescentes obesos. Sujeitos e métodos: A amostra foi composta por 24 obesos e 51 eutróficos controles. Inicialmente e após 12 semanas foram avaliados: peso, estatura, IMC, circunferência abdominal (CA), percentual de gordura (%G), consumo máximo de oxigênio (VO 2 máx), pressão arterial sistólica (PAS) e diastólica (PAD), glicemia (GLI) e insulinemia (INS) basal e após 120 min, triacilglicerol (TG), colesterol total (CT), colesterol LDL, colesterol HDL e a atividade da BChE (kU/l). Resultados: Após a intervenção, houve redução significativa no IMC, CA, %G, PAD, PAD, TG, GLI 120, INS, INS 120 min e na atividade da BChE. Conclusão: A redução da atividade da BChE, observada após a intervenção, foi acompanhada da redução de variáveis associadas a risco cardiovascular e à obesidade, indicando que a BChE pode ser utilizada como marcador secundário para os riscos associados à obesidade precoce. Arq Bras Endocrinol Metab. 2013;57(7):533-7 Descritores Exercício físico; atividade da BChE; obesidade precoce ABSTRACT Objective: To evaluate the effect of 12 weeks of physical exercise (PE) on cardiovascular risk factors and BChE activity in obese adolescents. Subjects and methods: The sample consisted of 24 obese adolescents and 51 normal weight controls. The following variables were measured in the initial stage and after 12 weeks: weight, height, BMI, waist circumference (WC), fat percentage (% F), maximal oxygen uptake (VO 2 max), systolic (SBP) and diastolic (DBP) blood pressure, glucose (GLY) and insulin (INS) at baseline and after 120 min, triacylglycerol (TG), total cholesterol (TC), LDL cholesterol, HDL cholesterol, and BChE activity (kU/l). Results: After the intervention, there was significant reduction in BMI, WC, %F, TG, GLI 120, INS 120 min, and BChE activity. Conclusion: The reduction in BChE activity, observed after physical exercise, was accompanied by the reduction of the variables associated with cardiovascular risk and obesity, indicating that BChE can be used as a secondary marker for the risk associated with early onset obesity. Arq Bras Endocrinol Metab. 2013;57 (7) INTRODUÇÃO A prevalência de sobrepeso e obesidade tem aumentado nesta década, e o desafio para os profissionais da área da saúde está na prevenção e na terapêutica adotada para redução do excesso de peso. O interesse para o maior entendimento dos mecanismos envolvidos no controle ponderal cresceu principalmente pelo aumento na prevalência do excesso de peso em todas as faixas etárias (1,2).
The aim of the present study was to evaluate the effect of a 12 week program of physical exercise (PE) on butyrylcholinesterase (BChE) in obese adolescents. This study compared obese adolescents (N = 54) before and after PE, regarding the relative intensity (RI) and activity of different molecular forms (G1, G2, G4 and G1-ALB) of BChE found in plasma. Waist circumference (WC) and lipid profile were also assessed before and after PE. It was shown that before PE, mean plasma BChE activity was significantly higher in obese than in non-obese adolescents and that it was significantly reduced after PE, becoming similar to that found in non-obese adolescents. Lipid profile and WC also changed in response to PE. These results are consistent with studies that found a correlation between BChE and lipid metabolism and suggest that PE may have led to a physiological regularization of plasma BChE activity. Although mean BChE activity of each isoform was significantly reduced by PE, their RI did not change. This is in accordance with a previous suggestion that this proportion is maintained under factors such as obesity, and may therefore be important for BChE functions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.